Food Allergy Market Report and Forecast 2025-2034
Description
The food allergy market size was valued at USD 39.03 Billion in 2024, driven by the increasing incidence of food allergies and increased awareness among people across the 7 major markets. The market size is anticipated to grow at a CAGR of 5.40% during the forecast period of 2025-2034 to achieve a value of USD 66.04 Billion by 2034.
Food Allergy: Introduction
Food allergy is a condition that occurs when a person’s immune system gets triggered by a particular food item and exhibits several symptoms depending on the person and the food item. Most symptoms are visible only for a few hours. In severe cases, such as anaphylaxis, symptoms may persist for several days. Symptoms of food allergies include tingling or itching in the mouth, itchy red rash, swelling of the face, mouth, throat, or other areas of the body, difficulty swallowing, wheezing or shortness of breath, digestive problems, and swollen airways among others.
Food Allergy Market Analysis
The market is driven by factors such as the rising prevalence of food allergies among children and adults. Due to the increasing prevalence, research institutes and key players in the market are expanding their sources and focusing on developing the best treatment for food-allergic patients across the 7 major markets. The continuous development of innovative solutions in the market can result in increased adoption as a major population is suffering from a common food allergy, especially to peanuts. This innovative technology and its increased adoption are also expected to trigger research and development activities to find solutions for other food allergies including tree nuts, propelling the food allergy market growth.
Additionally, a new research and innovation project is targeting the development of novel immunotherapeutic drugs for peanut and multiple tree nut allergies. The project is a collaboration between DTU National Food Institute, The Hospital for Sick Children (SickKids) in Canada, and the pharmaceutical company ALK. The project ALLEVIATE2 will complete the preclinical development of sublingual immunotherapy drug candidates for the treatment of peanut allergy first. If this goes well and happens to be successful, the project will subsequently apply the same therapeutic approach and develop new treatments for tree nut allergies as well. This project has been funded with 18.5 million DKK (Danish Krone) by the Innovation Fund Denmark.
Innovations and research activities in the field of food allergies have been driving the market growth due to the limited treatment options available in the. These efforts from researchers and institutes can assist pharmaceutical and biotechnology companies in developing new treatments that can improve the quality of life for food allergy patients, further boosting the market.
Food Allergy Market Segmentations
“Food Allergy Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Food Source
The market is driven by the increasing population allergic to food items. Rising investments in research and development activities targeted toward comprehending the mechanism of food allergies and the development of suitable treatments, drugs, and other innovative solutions are contributing to the market growth. The growing awareness of this condition among more people coupled with the increased demand for effective management and treatment options is expected to drive the food allergy market growth in the forecast period. The market growth is also attributed to increased investments by the government in research activities by scientists and key market players coupled with advanced development of technologies.
The Centers for Disease Control & Prevention (CDC) estimates that almost 6% of U.S. adults and children have a food allergy. The most common food allergies among Americans are shellfish, peanuts, milk, and tree nuts. About 200,000 Americans seek emergency medical care for life-threatening allergic reactions to food, known as anaphylaxis, each year. These medical conditions approximately contribute to USD 25 billion every year, driving the market growth.
Food Allergy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Food Allergy: Introduction
Food allergy is a condition that occurs when a person’s immune system gets triggered by a particular food item and exhibits several symptoms depending on the person and the food item. Most symptoms are visible only for a few hours. In severe cases, such as anaphylaxis, symptoms may persist for several days. Symptoms of food allergies include tingling or itching in the mouth, itchy red rash, swelling of the face, mouth, throat, or other areas of the body, difficulty swallowing, wheezing or shortness of breath, digestive problems, and swollen airways among others.
Food Allergy Market Analysis
The market is driven by factors such as the rising prevalence of food allergies among children and adults. Due to the increasing prevalence, research institutes and key players in the market are expanding their sources and focusing on developing the best treatment for food-allergic patients across the 7 major markets. The continuous development of innovative solutions in the market can result in increased adoption as a major population is suffering from a common food allergy, especially to peanuts. This innovative technology and its increased adoption are also expected to trigger research and development activities to find solutions for other food allergies including tree nuts, propelling the food allergy market growth.
Additionally, a new research and innovation project is targeting the development of novel immunotherapeutic drugs for peanut and multiple tree nut allergies. The project is a collaboration between DTU National Food Institute, The Hospital for Sick Children (SickKids) in Canada, and the pharmaceutical company ALK. The project ALLEVIATE2 will complete the preclinical development of sublingual immunotherapy drug candidates for the treatment of peanut allergy first. If this goes well and happens to be successful, the project will subsequently apply the same therapeutic approach and develop new treatments for tree nut allergies as well. This project has been funded with 18.5 million DKK (Danish Krone) by the Innovation Fund Denmark.
Innovations and research activities in the field of food allergies have been driving the market growth due to the limited treatment options available in the. These efforts from researchers and institutes can assist pharmaceutical and biotechnology companies in developing new treatments that can improve the quality of life for food allergy patients, further boosting the market.
Food Allergy Market Segmentations
“Food Allergy Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Food Source
- Dairy Products
- Poultry Product
- Tree Nuts
- Peanuts
- Shellfish
- Wheat
- Soy
- Others
- Anaphylaxis
- Atopic Dermatitis
- Others
- Skin-Prick Tests
- Blood Test
- Elimination Diet
- Oral Food Challenge
- Others
- Epinephrine
- Oral Immunotherapy
- Antihistamines
- Others
- United States
- United Kingdom
- Germany
- France
- Italy
- Spain
- Japan
The market is driven by the increasing population allergic to food items. Rising investments in research and development activities targeted toward comprehending the mechanism of food allergies and the development of suitable treatments, drugs, and other innovative solutions are contributing to the market growth. The growing awareness of this condition among more people coupled with the increased demand for effective management and treatment options is expected to drive the food allergy market growth in the forecast period. The market growth is also attributed to increased investments by the government in research activities by scientists and key market players coupled with advanced development of technologies.
The Centers for Disease Control & Prevention (CDC) estimates that almost 6% of U.S. adults and children have a food allergy. The most common food allergies among Americans are shellfish, peanuts, milk, and tree nuts. About 200,000 Americans seek emergency medical care for life-threatening allergic reactions to food, known as anaphylaxis, each year. These medical conditions approximately contribute to USD 25 billion every year, driving the market growth.
Food Allergy Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries
- Sanofi
- Boehringer Ingelheim International GmbH
- AstraZeneca
- Johnson & Johnson Private Limited
- Bayer AG
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Food Allergy Overview
- 3.1 Guidelines and Stages
- 3.2 Pathophysiology
- 3.3 Screening and Diagnosis
- 3.4 Treatment Pathway
- 4 Patient Profile
- 4.1 Patient Profile Overview
- 4.2 Patient Psychology and Emotional Impact Factors
- 4.3 Risk Assessment and Treatment Success Rate
- 5 Food Allergy Epidemiology Analysis – 7MM
- 5.1 7MM Epidemiology Scenario Overview (2018-2034)
- 5.2 United States Food Allergy Epidemiology Forecast (2018-2034)
- 5.3 EU-4 and United Kingdom Food Allergy Epidemiology Forecast (2018-2034)
- 5.3.1 Germany Food Allergy Epidemiology Forecast (2018-2034)
- 5.3.2 France Food Allergy Epidemiology Forecast (2018-2034)
- 5.3.3 Italy Food Allergy Epidemiology Forecast (2018-2034)
- 5.3.4 Spain Food Allergy Epidemiology Forecast (2018-2034)
- 5.3.5 United Kingdom Food Allergy Epidemiology Forecast (2018-2034)
- 5.4 Japan Food Allergy Epidemiology Forecast (2018-2034)
- 6 Food Allergy Market Overview – 7MM
- 6.1 Food Allergy Market Historical Value (2018-2024)
- 6.2 Food Allergy Market Forecast Value (2025-2034)
- 7 Food Allergy Market Landscape – 7MM
- 7.1 Food Allergy Therapeutics Developers Landscape
- 7.1.1 Analysis by Year of Establishment
- 7.1.2 Analysis by Company Size
- 7.1.3 Analysis by Region
- 7.2 Food Allergy Therapeutics Product Landscape
- 7.2.1 Analysis by Products
- 7.2.2 Analysis by Indications
- 7.2.3 Analysis by Route of Administration
- 8 Food Allergy Challenges and Unmet Needs
- 8.1 Treatment Pathway Challenges
- 8.2 Compliance and Drop-Out Analysis
- 8.3 Awareness and Prevention Gaps
- 9 Cost of Treatment
- 10 Food Allergy Market Dynamics
- 10.1 Market Drivers and Constraints
- 10.2 SWOT Analysis
- 10.3 Porter’s Five Forces Model
- 10.4 Key Demand Indicators
- 10.5 Key Price Indicators
- 10.6 Industry Events, Initiatives, and Trends
- 10.7 Value Chain Analysis
- 11 Food Allergy Market Segmentation – 7MM
- 11.1 Food Allergy Market by Food Source
- 11.1.1 Market Overview
- 11.1.2 Dairy Products
- 11.1.3 Poultry Product
- 11.1.4 Tree Nuts
- 11.1.5 Peanuts
- 11.1.6 Shellfish
- 11.1.7 Wheat
- 11.1.8 Soy
- 11.1.9 Others
- 11.2 Food Allergy Market by Symptoms
- 11.2.1 Market Overview
- 11.2.2 Anaphylaxis
- 11.2.3 Atopic Dermatitis
- 11.2.4 Others
- 11.3 Food Allergy Market by Diagnosis Test
- 11.3.1 Skin-Prick Tests
- 11.3.2 Blood Test
- 11.3.3 Elimination Diet
- 11.3.4 Oral Food Challenge
- 11.3.5 Others
- 11.4 Food Allergy Market by Treatment Type
- 11.4.1 Market Overview
- 11.4.2 Epinephrine
- 11.4.3 Oral Immunotherapy
- 11.4.4 Antihistamines
- 11.4.5 Others
- 11.5 Food Allergy Market by Region
- 11.5.1 Market Overview
- 11.5.2 United States
- 11.5.3 EU-4 and the United Kingdom
- 11.5.3.1 Germany
- 11.5.3.2 France
- 11.5.3.3 Italy
- 11.5.3.4 Spain
- 11.5.3.5 United Kingdom
- 11.5.4 Japan
- 12 United States Food Allergy Market
- 12.1 Food Allergy Market Historical Value (2018-2024)
- 12.2 Food Allergy Market Forecast Value (2025-2034)
- 12.3 Food Allergy Market by Disease Type
- 12.4 Food Allergy Market by Treatment Type
- 13 EU-4 and United Kingdom Food Allergy Market
- 13.1 Food Allergy Market Historical Value (2018-2024)
- 13.2 Food Allergy Market Forecast Value (2025-2034)
- 13.3 Germany Food Allergy Market Overview
- 13.3.1 Food Allergy Market by Disease Type
- 13.3.2 Food Allergy Market by Treatment Type
- 13.4 France Food Allergy Market Overview
- 13.4.1 Food Allergy Market by Disease Type
- 13.4.2 Food Allergy Market by Treatment Type
- 13.5 Italy Food Allergy Market Overview
- 13.5.1 Food Allergy Market by Disease Type
- 13.5.2 Food Allergy Market by Treatment Type
- 13.6 Spain Food Allergy Market Overview
- 13.6.1 Food Allergy Market by Disease Type
- 13.6.2 Food Allergy Market by Treatment Type
- 13.7 United Kingdom Food Allergy Market Overview
- 13.7.1 Food Allergy Market by Disease Type
- 13.7.2 Food Allergy Market by Treatment Type
- 14 Japan Food Allergy Market
- 14.1 Food Allergy Market Historical Value (2018-2024)
- 14.2 Food Allergy Market Forecast Value (2025-2034)
- 14.2.1 Food Allergy Market by Disease Type
- 14.2.2 Food Allergy Market by Treatment Type
- 15 Patent Analysis
- 15.1 Analysis by Type of Patent
- 15.2 Analysis by Publication year
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Patent Age
- 15.5 Analysis by CPC Analysis
- 15.6 Analysis by Patent Valuation
- 15.7 Analysis by Key Players
- 16 Grants Analysis
- 16.1 Analysis by year
- 16.2 Analysis by Amount Awarded
- 16.3 Analysis by Issuing Authority
- 16.4 Analysis by Grant Application
- 16.5 Analysis by Funding Institute
- 16.6 Analysis by NIH Departments
- 16.7 Analysis by Recipient Organization
- 17 Clinical Trials Analysis
- 17.1 Analysis by Trial Registration Year
- 17.2 Analysis by Trial Status
- 17.3 Analysis by Trial Phase
- 17.4 Analysis by Therapeutic Area
- 17.5 Analysis by Geography
- 18 Funding Analysis
- 18.1 Analysis by Funding Instances
- 18.2 Analysis by Type of Funding
- 18.3 Analysis by Funding Amount
- 18.4 Analysis by Leading Players
- 18.5 Analysis by Leading Investors
- 18.6 Analysis by Geography
- 19 Partnership and Collaborations Analysis
- 19.1 Analysis by Partnership Instances
- 19.2 Analysis by Type of Partnership
- 19.3 Analysis by Leading Players
- 19.4 Analysis by Geography
- 20 Supplier Landscape
- 20.1 Pfizer Inc.
- 20.1.1 Financial Analysis
- 20.1.2 Product Portfolio
- 20.1.3 Demographic Reach and Achievements
- 20.1.4 Mergers and Acquisition
- 20.1.5 Certifications
- 20.2 GlaxoSmithKline plc
- 20.2.1 Financial Analysis
- 20.2.2 Product Portfolio
- 20.2.3 Demographic Reach and Achievements
- 20.2.4 Mergers and Acquisition
- 20.2.5 Certifications
- 20.3 Novartis AG
- 20.3.1 Financial Analysis
- 20.3.2 Product Portfolio
- 20.3.3 Demographic Reach and Achievements
- 20.3.4 Mergers and Acquisition
- 20.3.5 Certifications
- 20.4 Mylan N.V.
- 20.4.1 Financial Analysis
- 20.4.2 Product Portfolio
- 20.4.3 Demographic Reach and Achievements
- 20.4.4 Mergers and Acquisition
- 20.4.5 Certifications
- 20.5 Teva Pharmaceutical Industries
- 20.5.1 Financial Analysis
- 20.5.2 Product Portfolio
- 20.5.3 Demographic Reach and Achievements
- 20.5.4 Mergers and Acquisition
- 20.5.5 Certifications
- 20.6 Sanofi
- 20.6.1 Financial Analysis
- 20.6.2 Product Portfolio
- 20.6.3 Demographic Reach and Achievements
- 20.6.4 Mergers and Acquisition
- 20.6.5 Certifications
- 20.7 Boehringer Ingelheim International GmbH
- 20.7.1 Financial Analysis
- 20.7.2 Product Portfolio
- 20.7.3 Demographic Reach and Achievements
- 20.7.4 Mergers and Acquisition
- 20.7.5 Certifications
- 20.8 AstraZeneca
- 20.8.1 Financial Analysis
- 20.8.2 Product Portfolio
- 20.8.3 Demographic Reach and Achievements
- 20.8.4 Mergers and Acquisition
- 20.8.5 Certifications
- 20.9 Johnson & Johnson Private Limited
- 20.9.1 Financial Analysis
- 20.9.2 Product Portfolio
- 20.9.3 Demographic Reach and Achievements
- 20.9.4 Mergers and Acquisition
- 20.9.5 Certifications
- 20.10 Bayer AG
- 20.10.1 Financial Analysis
- 20.10.2 Product Portfolio
- 20.10.3 Demographic Reach and Achievements
- 20.10.4 Mergers and Acquisition
- 20.10.5 Certifications
- 21 Food Allergy Market - Distribution Model (Additional Insight)
- 21.1 Overview
- 21.2 Potential Distributors
- 21.3 Key Parameters for Distribution Partner Assessment
- 22 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 23 Company Competitiveness Analysis (Additional Insight)
- 23.1 Very Small Companies
- 23.2 Small Companies
- 23.3 Mid-Sized Companies
- 23.4 Large Companies
- 23.5 Very Large Companies
- 24 Payment Methods (Additional Insight)
- 24.1 Government Funded
- 24.2 Private Insurance
- 24.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
